Claro Otic Solution

Verify with FDA CVM →

26 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
26
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Claro Otic Solution

Administration Routes

Auricular (Otic)Unknown

Species Affected

Dog 26

Most Affected Breeds

Retriever - Labrador 3
Shepherd Dog - German 3
Chihuahua 2
Bichon Frise 2
Mixed (Dog) 2
Pug 2
Bulldog - English 2
Retriever - Golden 2
Brittany 2
Spaniel - Springer (unspecified) 1

Most Reported Reactions

Vomiting 6
Lethargy (see also Central nervous system depression in Neurological) 6
Panting 5
Seizure NOS 3
Elevated alanine aminotransferase (ALT) 3
Elevated serum alkaline phosphatase (ALP) 3
Disorientation 2
Falling 2
Not sleeping 2
Whining 2
Cough 2
Lymphocytosis 2

Outcome Breakdown

Ongoing
22 (84.6%)
Recovered/Normal
3 (11.5%)
Outcome Unknown
1 (3.8%)

Data Summary

Metric Value
Total adverse event reports 26
Reports involving death 0
Case-fatality rate (reported events) 0.0%
Distinct species in reports 1
Distinct breeds in reports 15
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Claro Otic Solution Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 26 adverse event reports referencing Claro Otic Solution, including 0 reports in which the animal died — a 0.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Claro Otic Solution. Reported administration routes include Auricular (Otic), Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Claro Otic Solution reports are Dog (26 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (3), Shepherd Dog - German (3), Chihuahua (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Claro Otic Solution are Vomiting (6), Lethargy (see also Central nervous system depression in Neurological) (6), Panting (5), Seizure NOS (3). Of the 26 reports with a coded outcome, Ongoing is the leading category at 84.6%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Claro Otic Solution.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial